Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · IEX Real-Time Price · USD
54.36
+1.02 (1.91%)
At close: Jul 26, 2024, 4:00 PM
55.44
+1.08 (1.99%)
After-hours: Jul 26, 2024, 6:08 PM EDT
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $4.29 billion as of July 26, 2024. Its market cap has increased by 297.33% in one year.
Market Cap
4.29B
Enterprise Value
3.44B
1-Year Change
297.33%
Ranking
Category
Stock Price
$54.36
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $539.40M to $4.29B, an increase of 694.74%. That is a compound annual growth rate of 41.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 4.21B | 76.98% |
| Dec 29, 2023 | 2.38B | 141.36% |
| Dec 30, 2022 | 984.70M | -27.03% |
| Dec 31, 2021 | 1.35B | 190.53% |
| Dec 31, 2020 | 464.50M | -23.56% |
| Dec 31, 2019 | 607.70M | -15.70% |
| Dec 31, 2018 | 720.90M | 33.65% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CRISPR Therapeutics AG | 4.86B |
| RadNet | 4.81B |
| Haemonetics | 4.67B |
| Apellis Pharmaceuticals | 4.48B |
| Avidity Biosciences | 4.40B |
| Dyne Therapeutics | 4.31B |
| Alkermes | 4.23B |
| Integer Holdings | 4.22B |